De Facto hosts webcast 'Dare to Go Digital'
De Facto hosts webcast exploring views on web marketing and 'Going Digital'. The panel of experts includes Shipra Singh, Managing Director of Bell Pottinger Health, Ben Chodor, President of Stream57 and Matt McKay, Head of PR at BioMed Central. View the webcast. |
De Facto appointed to act as conference organiser for eMarketing Seminar
De Facto has been appointed by BioMed Central to act as conference organiser for 'Going Digital eMarketing Seminar for the Pharmaceutical and Healthcare sectors' on 20th May at the Royal Society in London. Visit the event website to register. |
De Facto hosts webcast 'Seven steps to successful webcasting'
De Facto has been appointed by In Situ Productions to promote its webcast production services. As part of this programme, In Situ offered to share the benefit of its experience with Bell Pottinger Group in the form of an interactive webcast. |
De Facto promotes CGT Relief campaign
De Facto and G-Nostics Ltd have launched a campaign to put forward the views of small SMEs and entrepreneurs, who want to maintain Capital Gains Tax (CGT) taper relief at 10% for biotechnology start-up founders and staff. View the open letter, sign the petition or complete the survey.
|
Effective Patient Recruitment
Some studies suggest that the biggest delay to 40% of clinical trials is failure to recruit and retain sufficient patients. As competition for patients grows ever fiercer, increasingly sophisticated communication campaigns are needed to put companies ahead of their competitors. View
article |
Speedel wins Award
Speedel and Novartis have won the overall Gold Award in the 7th annual Wall Street Journal contest for Technology Innovation for discovering and developing aliskiren as a major breakthrough for treatment of hypertension. View
press release |
BioTrinity
2007
The inaugural BioTrinity 2007 was a great success, becoming the largest
biotech & healthcare partnering conference in the Oxford and South
East biotech region, with over 400 delegates, 285 companies, 180 licensing
opportunities and 520 one-to-one partnering meetings. View
videocast |